These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1527230)

  • 1. Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment.
    Angrist B; d'Hollosy M; Sanfilipo M; Satriano J; Diamond G; Simberkoff M; Weinreb H
    J Clin Psychopharmacol; 1992 Aug; 12(4):268-72. PubMed ID: 1527230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychostimulant response in AIDS-related complex patients.
    Holmes VF; Fernandez F; Levy JK
    J Clin Psychiatry; 1989 Jan; 50(1):5-8. PubMed ID: 2642894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge.
    Herrmann N; Rothenburg LS; Black SE; Ryan M; Liu BA; Busto UE; Lanctôt KL
    J Clin Psychopharmacol; 2008 Jun; 28(3):296-301. PubMed ID: 18480686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial aspects of AIDS.
    Goldmeier D
    Br J Hosp Med; 1987 Mar; 37(3):232-4, 238-40. PubMed ID: 3828647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.
    Lee H; Kim SW; Kim JM; Shin IS; Yang SJ; Yoon JS
    Hum Psychopharmacol; 2005 Mar; 20(2):97-104. PubMed ID: 15641125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process.
    Harel Y; Appleboim N; Lavie M; Achiron A
    J Neurol Sci; 2009 Jan; 276(1-2):38-40. PubMed ID: 18817930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychostimulants for depression in hospitalized cancer patients.
    Olin J; Masand P
    Psychosomatics; 1996; 37(1):57-62. PubMed ID: 8600496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychostimulant treatment of depressive disorders secondary to medical illness.
    Woods SW; Tesar GE; Murray GB; Cassem NH
    J Clin Psychiatry; 1986 Jan; 47(1):12-5. PubMed ID: 3941052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric aspects of AIDS and psychopharmacologic management.
    Gilmer WS; Busch KA
    Psychiatr Med; 1991; 9(2):313-29. PubMed ID: 1857766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
    Leitner Y; Doniger GM; Barak R; Simon ES; Hausdorff JM
    J Child Neurol; 2007 Mar; 22(3):264-76. PubMed ID: 17621495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric aspects of AIDS dementia complex: a report on a clinical series.
    Boccellari A; Dilley JW; Shore MD
    Neurotoxicology; 1988; 9(3):381-9. PubMed ID: 3200506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment due to AIDS-related complex and its response to psychostimulants.
    Fernandez F; Adams F; Levy JK; Holmes VF; Neidhart M; Mansell PW
    Psychosomatics; 1988; 29(1):38-46. PubMed ID: 2893426
    [No Abstract]   [Full Text] [Related]  

  • 13. L-acetylcarnitine treatment of mental decline in the elderly.
    Salvioli G; Neri M
    Drugs Exp Clin Res; 1994; 20(4):169-76. PubMed ID: 7813389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of HIV-related depression to psychostimulants: case reports.
    Fernandez F; Levy JK; Galizzi H
    Hosp Community Psychiatry; 1988 Jun; 39(6):628-31. PubMed ID: 3402922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. d-Amphetamine versus methylphenidate effects in depressed inpatients.
    Little KY
    J Clin Psychiatry; 1993 Sep; 54(9):349-55. PubMed ID: 8407854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute neuropsychiatric manifestations in HIV infection: apropos of 5 clinical cases].
    Kerneis H; Estrade JF; Samuel-Lajeunesse B
    Ann Med Psychol (Paris); 1991 Apr; 149(4):365-72. PubMed ID: 1958042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive impairment in alcoholics: review and comparison with cognitive impairment due to AIDS.
    Pohl MI
    Adv Alcohol Subst Abuse; 1987; 7(2):107-16. PubMed ID: 3329445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
    Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P
    J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.
    Levin FR; Evans SM; Brooks DJ; Kalbag AS; Garawi F; Nunes EV
    Drug Alcohol Depend; 2006 Feb; 81(2):137-48. PubMed ID: 16102908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings.
    Cherner M; Ellis RJ; Lazzaretto D; Young C; Mindt MR; Atkinson JH; Grant I; Heaton RK;
    AIDS; 2004 Jan; 18 Suppl 1():S27-34. PubMed ID: 15075495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.